Settlement funds intended to address the long-standing opioid addiction and overdose epidemic are being distributed to communities across the United States. However, there are concerns that some of this money may not be utilized effectively to combat the crisis.
With over 800,000 opioid-related deaths in the U.S. since 1999, including a significant number involving illicit fentanyl, the need for targeted intervention is critical. Various settlements with drug manufacturers and distributors, totaling potentially more than $50 billion over nearly two decades, come with obligations to enhance prescription monitoring and transparency.
